Jon Blaskovich
Chief Tech/Sci/R&D Officer presso BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Posizioni attive di Jon Blaskovich
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Chief Tech/Sci/R&D Officer | - | - |
| BIOHAVEN LTD. | Chief Tech/Sci/R&D Officer | - | - |
Storia della carriera di Jon Blaskovich
Precedenti posizioni note di Jon Blaskovich
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Epsilon Data Management LLC
 Epsilon Data Management LLC Advertising/Marketing ServicesCommercial Services Epsilon Data Management LLC provides marketing and data management services. It offers multi channel marketing, technologies and database solutions, strategic consulting, and account management services. The company was founded in 1969 and is headquartered in Irving, TX. | Chief Tech/Sci/R&D Officer | - | - |
Formazione di Jon Blaskovich
| Rochester Institute of Technology | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Australia | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOHAVEN LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Epsilon Data Management LLC
Epsilon Data Management LLC Advertising/Marketing ServicesCommercial Services Epsilon Data Management LLC provides marketing and data management services. It offers multi channel marketing, technologies and database solutions, strategic consulting, and account management services. The company was founded in 1969 and is headquartered in Irving, TX. | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Borsa valori
- Insiders
- Jon Blaskovich
- Esperienza
